Stock Events

Stock Events

AcuityAds 

C$20.32
143
+C$0.00+0%Wednesday 17:48

Statistics

Day High
20.32
Day Low
20.32
52W High
20.32
52W Low
20.32
Volume
300
Avg. Volume
-
Mkt Cap
1.07B
P/E Ratio
74.33
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 5Expected
Q3 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q2 2026
Q3 2026
-0.08
-0.04
0.01
0.05
Expected EPS
-0.03936503868
Actual EPS
-0.029592794829405276

Financials

-10.21%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
143.59MRevenue
-14.66MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AT.TO. It's not an investment recommendation.
Apple
18
AAPL
Bank Of Nova Scotia
18
BNS.TO
Enbridge
17
ENB.TO
Lightspeed Commerce
17
LSPD.TO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap35.63B
Illumina, Inc. is a direct competitor in the genomic sequencing space, offering similar sequencing and array technologies.
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
Thermo Fisher Scientific provides comprehensive solutions including instruments, reagents, and software for research, analysis, discovery, and diagnostics that compete with Illumin's offerings.
Pacific Biosciences of California
PACB
Mkt Cap809.71M
Pacific Biosciences of California offers long-read sequencing technologies that compete with Illumin's short-read sequencing platforms.
Bio-Rad Laboratories
BIO
Mkt Cap9.95B
Bio-Rad Laboratories, Inc. offers a range of products for the life science research and clinical diagnostics markets, competing in the genomic and molecular diagnostics space.
Qiagen NV
QGEN
Mkt Cap10.37B
Qiagen N.V. provides sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the nucleic acid solutions market.
Agilent Technologies
A
Mkt Cap49.3B
Agilent Technologies, Inc. provides instruments, software, services, and consumables for the entire laboratory workflow, competing with Illumin in the genomics and molecular diagnostics sectors.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG offers diagnostic and research tools that compete with Illumin's genomic solutions, particularly in the sequencing and array-based technologies.
Quest Diagnostics
DGX
Mkt Cap27.79B
Quest Diagnostics incorporates genomic sequencing into its diagnostic testing services, competing indirectly with Illumin by offering similar diagnostic solutions.
Intellia Therapeutics
NTLA
Mkt Cap1.75B
Intellia Therapeutics, Inc. is involved in CRISPR/Cas9 technology, a gene editing technology that requires sequencing, indirectly competing with Illumin's sequencing technologies.
Editas Medicine
EDIT
Mkt Cap410.06M
Editas Medicine, Inc. also works in the gene editing space with CRISPR technology, relying on genomic sequencing technologies similar to those offered by Illumin for its research and development.

About

illumin Holdings Inc., a technology company, provides digital media solutions in Canada, the United States, Europe, Latin America, and internationally. The company offers a programmatic marketing platform that enables advertisers to connect with their audiences across video, mobile, out-of-home, social, CTV and online display advertising campaigns. Its platform also allows advertisers to manage their purchasing of online display advertising in real-time using programmatic ad buying. In addition, the company offers illumin platform, an advertising automation technology that provides planning, media buying, and omnichannel intelligence, as well as allows advertisers to map their consumer journey playbooks across screens and execute in real-time using programmatic technology. It serves Fortune 500 enterprises and small to mid-sized businesses. The company was formerly known as AcuityAds Holdings Inc. and changed its name to illumin Holdings Inc. in June 2023. illumin Holdings Inc. was founded in 2009 and is headquartered in Toronto, Canada.
Show More
CEO
Tal Hayek
Employees
196
Country
Canada
ISIN
CA00510L1067
WKN
000A3EH59

Listings

MU
DE
K3S0.MU
MU
DE
K3S.MU
STU
DE
K3S0.STU
STU
DE
K3S.STU

0 Comments

Share your thoughts

FAQs

What is AcuityAds stock price today?▼
The current price of AT.TO is C$20.32 CAD — it has increased by +0% in the past 24 hours. Watch AcuityAds stock price performance more closely on the chart.
What is AcuityAds stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Toronto Exchange exchange AcuityAds stocks are traded under the ticker AT.TO.
What is AcuityAds market cap?▼
Today AcuityAds has the market capitalization of 1.07B
When is the next AcuityAds earnings date?▼
AcuityAds is going to release the next earnings report on March 11, 2027.
What were AcuityAds earnings last quarter?▼
AT.TO earnings for the last quarter are -0.03 CAD per share, whereas the estimation was -0.04 CAD resulting in a +24.82% surprise. The estimated earnings for the next quarter are N/A CAD per share.
What is AcuityAds revenue for the last year?▼
AcuityAds revenue for the last year amounts to 143.59M CAD.
What is AcuityAds net income for the last year?▼
AT.TO net income for the last year is -14.66M CAD.
How many employees does AcuityAds have?▼
As of November 7, 2026, the company has 196 employees.
In which sector is AcuityAds located?▼
AcuityAds operates in the Communication sector.
When did AcuityAds complete a stock split?▼
AcuityAds has not had any recent stock splits.
Where is AcuityAds headquartered?▼
AcuityAds is headquartered in Toronto, Canada.